je.st
news
Tag: therapeutics
United Therapeutics Shares Gain on FDA Hypertension Approval
2013-12-24 06:27:41| Biotech - Topix.net
United Therapeutics Corp. gained the most in six years, after winning U.S. marketing approval for the oral version of its treatment for high blood pressure in the arteries that supply the lungs.
Tags: united
gain
approval
shares
Esperion Therapeutics Added to the NASDAQ Biotechnology Index
2013-12-24 02:03:23| Biotech - Topix.net
Esperion Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol lowering therapies for the treatment of hypercholesterolemia, today announced that the company has been added to the NASDAQ Biotechnology Index effective prior to the market ... (more)
Tags: index
added
nasdaq
biotechnology
Orexigen Therapeutics resubmits Contrave to FDA
2013-12-12 11:39:48| Biotech - Topix.net
The FDA refused to approve Contrave in 2011, citing concerns over cardiovascular risk.
Tags: fda
therapeutics
United Therapeutics Gets Subpoena Over 3 Drugs
2013-12-09 23:45:24| Biotech - Topix.net
Specialty drugmaker United Therapeutics Corp. said Monday that it received a subpoena from federal regulators looking into the company's marketing of three drugs used to treat a form of hypertension.
Tags: united
drugs
therapeutics
subpoena
ImStar Therapeutics Selects Lead Drug Candidate For ALS
2013-12-04 04:16:22| drugdiscoveryonline News Articles
ImStar Therapeutics today announced the selection of IMS-088 as its lead drug candidate for the treatment of Amyotrophic Lateral Sclerosis (ALS). The company is preparing to initiate IND-enabling studies in the second half of 2014
Sites : [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] next »